EFFECT OF TWO-MONTH TREATMENT WITH GROWTH HORMONE-RELEASING FACTOR ON GROWTH HORMONE RELEASE IN DAIRY COWS

1988 ◽  
Vol 68 (3) ◽  
pp. 731-740 ◽  
Author(s):  
H. LAPIERRE ◽  
G. PELLETIER ◽  
D. PETITCLERC ◽  
P. DUBREUIL ◽  
J. MORISSET ◽  
...  

Two experiments were conducted to examine the effect of a human growth hormone-releasing factor fragment (hGRF(1–29)NH2) on growth hormone (GH) secretion in lactating dairy cows. An initial study was conducted on 12 lactating dairy cows to determine the dose effect (5, 10 and 20 μg kg−1) of a subcutaneous (s.c.) injection of hGRF(1–29)NH2 on GH secretion. The three doses induced similar GH response, with peaks and areas under the curve (AUC) of 38.5, 41.2 and 38.0 ng mL−1, and 3496, 4112 and 4079 ng mL−1 min at 5, 10 and 20 μg kg−1, respectively. In a second study, the GH response after daily s.c. injections of saline (n = 8) or 10 μg kg−1 of hGRF(1–29)NH2 (n = 9) for 57 d was evaluated in dairy cows averaging 252 d in lactation. Blood samples were collected on d 1, 15, 29, 43 and 57 of treatment. On the last day of treatment, the GRF-induced GH peak was higher than on the first day, 46.8 vs. 25.2 ng mL−1, while the AUC was not different, 4010 vs. 2684 ng mL−1 min. Finally, to determine if the pituitary's ability to release GH was modified after 57 d of GRF treatment, the 17 cows were challenged with an intravenous injection of hGRF(1–29)NH2 (1 μg kg−1). Control cows had a lower peak (21.8 vs. 32.2 ng mL−1) but a similar AUC (2190 vs. 2579 ng mL−1 min) than GRF-treated cows. Hence, in lactating dairy cows, (1) s.c. administration of hGRF(1–29)NH2 induced a similar GH release with doses ranging from 5 to 20 μg kg−1 and (2) the GRF-induced GH peak was higher after 57 d of GRF treatment while the AUC was not different. Therefore, 2-mo GRF treatment of dairy cows during their two last month of lactation does not result in a decreased GH response to GRF. Key words: Growth hormone-releasing factor, growth hormone, cows (dairy)

1991 ◽  
Vol 71 (3) ◽  
pp. 707-715
Author(s):  
P. Lacasse ◽  
J. Morisset ◽  
D. Petitclerc ◽  
G. Pelletier ◽  
Y. Couture ◽  
...  

Forty-seven Holstein cows (51 ± 7 d of lactation; 607 ± 78 kg BW) were randomly subjected to a 2 × 2 factorial arrangement based on milk production. Milk production and feed intake were recorded every day and milk and feed composition determined once a week for 33 wk (4 wk preinjection, 26 wk of injection and 3 wk postinjection). During the injection period, cows received daily s.c. injections (10:00 h) in the cervical area of saline (control), human growth hormone-releasing factor (1–29)NH2 (GRF; 10 μg kg−1 BW), thyrotropin-releasing factor (TRF; 1 μg kg−1 BW) or the combination of both releasing factors (10 and 1 μg kg−1 BW, respectively). Growth hormone-releasing factor enhanced milk production (P < 0.001; 22.1 vs. 24.2 kg 4% FCM per d), feed intake (P < 0.05; 19.0 vs. 19.8 kg DM per d), feed efficiency (P < 0.05; 1.14 vs. 1.21 kg 4% FCM per kg DM) and insulin-like growth factor-I concentrations (P < 0.05) but did not affect milk composition (P > 0.25) or average daily weight gain (P > 0.25). Thyrotropin-releasing factor did not affect nor did it interact with GRF on any of these variables except for average daily weight gain which was reduced by TRF (P < 0.05; 0.24 vs. 0.12 kg d−1) during the injection period. Milk production of GRF-treated cows returned to control levels after 3 wk following cessation of treatment. GRF treatment depressed (P < 0.05) serum urea, creatinine, triglycerides and glutamate pyruvate transaminase concentrations, while TRF treatment increased glucose levels (P < 0.05). In conclusion, daily s.c. injections of GRF for 6 months stimulated milk production by 9.5% and improved feed efficiency by 6.1% in dairy cows. Key words: GRF, TRF, milk production, plasma constituents, IGF-I


1995 ◽  
Vol 78 (4) ◽  
pp. 804-815 ◽  
Author(s):  
H. Lapierre ◽  
G. Pelletier ◽  
T. Abribat ◽  
K. Fournier ◽  
P. Gaudreau ◽  
...  

1985 ◽  
Vol 110 (2) ◽  
pp. 158-163 ◽  
Author(s):  
Philippe Garry ◽  
Bernard Roussel ◽  
Richard Cohen ◽  
Sylviane Biot-Laporte ◽  
Abdel Elm Charfi ◽  
...  

Abstract. hGRF (iv 50 μg) was administered to 6 normal young adult males at 09.00 and 20.00 h on different days. Nocturnal GH secretion was monitored during polygraphic sleep recordings on both control nights and nights following hGRF administration. Sleep-related GH secretion and sleep parameters were not affected by diurnal hGRF administration.


Sign in / Sign up

Export Citation Format

Share Document